Henry Schein Dental UK supports Cancer Research UK

Company Profiles
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Henry Schein Dental will support cancer awareness and research by Cancer Research UK through its “Practice Pink” programme

In October 2017, Henry Schein Dental UK will offer customers the opportunity to join the company in its fight against cancer by purchasing a range of pink products to help support Henry Schein’s Practice Pink programme – an initiative designed to raise awareness for cancer. Alongside this, Henry Schein Dental will make a donation to Cancer Research UK to support the battle against cancer.

Cancer Research UK wants survival in the UK to be among the best in the world. The organisation focuses its efforts in four key areas – working to help prevent cancer, diagnose it earlier, develop new treatments and optimise current treatments by personalising them and making them even more effective. The organisation’s work is funded solely by donations.

Now in its 13th year, the Practice Pink program has raised more than $1.3 million for the fight against cancer through the Henry Schein Cares Foundation, a nonprofit organisation that supports and promotes increased access to care globally. In 2016, the Practice Pink programme expanded to Europe, where Team Schein Members across the continent teamed up with supplier partners and non-governmental organizations to positively impact the lives of people battling cancer.

"Through the continued support of our customers and supplier partners, we at Henry Schein have been able to make considerable contributions to the fight against cancer, and we are pleased to see the Practice Pink programme expand to the European markets we serve," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Cancer is a health issue that touches every community in every corner of the globe, and it is only by working together that we will achieve our shared goal of a cancer-free world."

“Henry Schein is proud of the terrific response to this programme across Europe in 2016. We hope that with the generosity of our customers, supplier partners and Team Schein members, we can do even better this year and continue to positively impact the lives of countless patients and their families,” says Simon Gambold, Henry Schein’s Vice President Marketing European Dental Group.

The International Agency for Research on Cancer (IARC), the specialised cancer agency of the World Health Organization (WHO) stated in its World Cancer Report 2014 that in 2012, 3.4 million new cancer cases were diagnosed in Europe and an estimated 14 million new cases worldwide. WHO also said that cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. The United States National Cancer Institute has said that, based on data gathered from 2010 and 2012, approximately 39.6% of American citizens will be diagnosed with cancer at some point during their lifetimes.